← All stocks

SAB Biotherapeutics, Inc.

SABS Net buying
CIK 0001833214 #3457 in the set updated 22 Sep 2026
Bought (120 mo)
$12.71M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.20K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$2.20K
1 of 1 sales
Net
+$12.70M
+$12.70M against sales at will

By person

16 insiders · 15 transactions
6.3×

Samuel J. Reich holds 6.3 times base salary in stock. $3.36M of shares against $525.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Samuel J. Reich last reported holding, valued at $0.88, the price Common Stock was last bought or sold at on the open market here, on 7 Dec 2023.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Reich Samuel J
CEO
$4.19M (3)
+$4.19M
3,814,524
$3.36M
−32.8%
Katz Ilan
Director
$4.19M (3)
+$4.19M
3,049,325
$2.68M
+15.9%
Big Cypress Holdings LLC entity
CEO and CFO
$4.17M (1)
+$4.17M
3,047,825
$2.68M
+15.9%
Spragens Jeffrey G
Director
$130.91K (1)
+$130.91K
394,989
$347.59K
Sullivan Eddie Joe
PRESIDENT
$11.85K (2)
+$11.85K
5,232,304
$4.60M
HAMILTON CHRISTINE E
Director
$7.30K (1)
+$7.30K
8,104,424
$7.13M
King Michael
CHIEF FINANCIAL OFFICER
$4.50K (1)
+$4.50K
5,000
$4.40K
Beyer Russell P
Chief Financial Officer
$2.20K (1)
−$2.20K
2,475
$2.18K
Hamilton Edward D.
10% owner
10,023,848
$8.82M
Ellias Helen K.
Director
2,857,142
$2.51M
Moin Andrew
Director
2,198,457
$1.93M
Sessa Capital (Master), L.P. entity
Director
2,198,457
$1.93M
Link David Charles
Director
69,410
$61.08K
Kropotova Alexandra
CHIEF MEDICAL OFFICER
41,853
$36.83K
Finnegan Frederick
Chief Business Officer
38,596
$33.96K
Luke Thomas Charles
Chief Medical Officer
5,428
$4.78K

No percentages here. This company's share count has moved by a factor of 9.9 over the window, from 9,229,274 to 90,986,368 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Sullivan Eddie Joe
7 Dec 2023
Chief Executive Officer
Buy
1,740
$0.88
$1.53K
King Michael
30 Nov 2023
CHIEF FINANCIAL OFFICER
Buy
5,000
$0.90
$4.50K
Reich Samuel J
29 Nov 2023
Executive Chairman
Buy
11,000
$0.89
$9.84K
HAMILTON CHRISTINE E
13 Sep 2022
Director
Buy
10,000
$0.73
$7.30K
Sullivan Eddie Joe
7 Sep 2022
CHIEF EXECUTIVE OFFICER
Buy
14,000
$0.74
$10.32K
Reich Samuel J
14 Oct 2021
CEO and CFO
Buy
1,000
$10.11
$10.11K
Katz Ilan
13 Oct 2021
Director
Buy
500
$10.11
$5.05K
Katz Ilan
1 Oct 2021
Director
Buy
1,000
$10.09
$10.09K
Spragens Jeffrey G
1 Oct 2021
Director
Buy
13,000
$10.07
$130.91K
Big Cypress Holdings LLC
14 Jan 2021
CEO and CFO
Buy
417,200
$10.00
$4.17M
Katz Ilan
14 Jan 2021
Director
Buy indirect
417,200
$10.00
$4.17M
Reich Samuel J
14 Jan 2021
CEO and CFO
Buy indirect
417,200
$10.00
$4.17M

What was left out

Form 4 filings counted 112
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 44,807,679
Sales filed before the plan box existed 1
History held since 14 Jan 2021